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Impact of diagnostic misclassiﬁcation on estimation
of genetic correlations using genome-wide genotypes
Naomi R Wray*,1,2, Sang Hong Lee1,2 and Kenneth S Kendler3
Disorders that share genetic risk factors often are placed in closely related diagnostic categories and treated similarly. Until
recently, evidence for shared genetic etiology derived from classical research strategies – coaggregation in family and twin
studies. Accumulating sufﬁcient numbers of families was often problematic. However, in the era of genome-wide genotyping, we
can now directly estimate the degree of sharing of genetic risk factors between disorders. This strategy is practical even for very
rare disorders, where it is infeasible to ascertain informative families. Importantly, the estimates of genetic correlations from
genome-wide genotypes are derived using such distant relatives that contamination by shared environmental factors seems
unlikely. However, any method that seeks to quantify the shared etiology of disorders assumes they can be distinguished
diagnostically from one another without error. Here we investigate the impact of misdiagnosis on estimates of genetic correlation
both from traditional family data and from genome-wide genotypes of case–control samples from unrelated individuals. Our
analyses show similar results for levels of misdiagnosis in both types of data. In both scenarios, genetic variances and
heritabilities tend to be slightly underestimated but genetic correlations are overestimated, sometimes substantially so. For
example, two genetically distinct but equally heritable disorders each with prevalence 1%, can generate false-positive estimates
of genetic correlations of 40.2 in the presence of 10% reciprocal misdiagnosis. Strategies for minimizing the effects of
misdiagnosis in cross-disorder genetic studies are discussed.
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INTRODUCTION
Medical nosologies often seek to make their classiﬁcations based on an
understanding of the etiological relationship between disorders. That
is, as we classify syndromes into disorders and diseases and place them
into individual diagnostic categories, a recurrent question is the degree
of etiological overlap between them. Because of the consistent impor-
tance of familial/genetic factors, traditional genetic strategies, includ-
ing family and twin studies, have often been used to examine this
question, for example,1 in twin and family studies, the approach
utilized has been an examination of familial coaggregation – the
tendency for disorder A to occur in excess in the relatives of probands
with disorder B and vice versa. Such data can be used to estimate the
genetic correlation between the two disorders. Evidence that two
disorders strongly co-aggregate in families and/or have a high genetic
correlation would then suggest that they are closely etiologically
related and should be classiﬁed within a single super-ordinate category
or even as subtypes of one disorder.
However, such an approach assumes that the disorders can be
distinguished diagnostically from one another without error. For
many biomedical disorders, this assumption may not be true. For
example, a recent careful 10-year longitudinal study of 450 ﬁrst
admissions with psychosis based on research interviews showed that
over the 10-year period, 15% of subjects initially diagnosed with
bipolar disorder were re-diagnosed with schizophrenia, whereas 4% of
schizophrenia diagnoses were re-classiﬁed as bipolar disorder.2 In a
much larger sample, using the hospital records from the Danish
Psychiatric Central Register of all psychiatric inpatient admissions in
Denmark between 1970 and 2006, the diagnostic course of all 18820
ﬁrst-time admissions with either schizophrenia, bipolar disorder or
schizoaffective disorder was examined.3 This study produced results
broadly similar to the smaller study in that for ﬁrst-time admissions
for bipolar disorder (n¼3801) and schizophrenia (n¼12141), 15%
and 6%, respectively, had later admissions of one or more of the other
disorders (including schizoaffective disorder).
The genomics era now provides us with new opportunities to
explore the shared genetic etiology between disorders. Genome-wide
association studies (GWAS) measure genetic polymorphisms (eg,
single nucleotide polymorphisms, SNPs) at several hundred thousand
positions in the genome. New methods show how these data can be
used to estimate the proportion of variation in liability to disease that
is associated with SNPs,4 and these estimates represent a lower limit of
the heritability. These methods use very distant relationships between
individuals, so estimates are unlikely to be confounded with common
environmental effects, which can be difﬁcult to disentangle from the
genetic component of familiality in family studies. The methodology
can be extended to estimation of the genetic correlation between
different disorders that is tagged by SNPs. Evidence for a genetic
correlation between disorders estimated directly by interrogation of
the genome could have an important impact on the design of future
genetic and functional studies.
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www.nature.com/ejhgOver 20 years ago, one of us (KSK) developed a model to predict the
observed pattern of familial co-aggregation between two disorders that
w o u l db ee x p e c t e ds o l e l yo nd i a gnostic mis-classiﬁcation.5 We extend
this earlier work in two ways to understand how estimates of genetic
correlation derived from GWAS data may be inﬂuenced by diagnostic
misclassiﬁcation. Firstly, Kendler5 showed the impact of diagnostic
misclassiﬁcation on recurrence risks to relatives, but did not quantify
the impact on the estimates of genetic parameters because to do this
requires a critical assumption that common environment does not
impact on familiality. Here, we accept that critical assumption (which
for some disorders can be justiﬁed) and quantify the impact of
diagnostic misclassiﬁcation on estimates of the genetic parameters of
heritability and genetic correlation calculated from family studies, consi-
dering scenarios where the true genetic parameters take on a range of
values including a non-zero genetic correlation. Quantifying the impact
of misdiagnosis on genetic parameters from family data provides
important benchmarking for our second approach in which we consider
the impact of misclassiﬁcation on the estimation of genetic variance and
covariance parameters estimable from genome-wide SNP data.
METHODS
Estimation of genetic parameters from family data
Following Kendler,5 we consider two disorders A and B whose genetic
epidemiology can be deﬁned by 6 parameters KTA, KTB, lTA, lTB, MTA,M TB
and rgT: where KTA, KTB are the lifetime risks of the disorders, lTA and lTB are
the recurrence risks to ﬁrst-degree relatives of having the same disorder, MTA is
the misclassiﬁcation rate of disorder A as disorder B and MTB is the
misclassiﬁcation rate of disorder A as disorder B. rgT is the genetic correlation
between the disorders (note in Kendler5 this was always zero and so was not
speciﬁcally considered). We use the subscript T to emphasize that these
parameters refer to the true classiﬁcation of the disorders.
From these parameters, we can calculate other parameters for the true
disorders: the heritabilities of the disorders on the liability scale, h2
TA and h2
TB
(see Appendix), under the critical assumption that all familiality represented in
the recurrence risk is of additive genetic origin, and the lifetime risk of the
disorders in ﬁrst-degree relatives KTA/TA, KTB/TB, KTA/TB, KTB/TA. The subscripts
refer to true disorder of proband/true disorder of ﬁrst-degree relative. However,
the true disorders are not observed, only the diagnosed disorders are observed;
we use the symbol D in the subscript to denote parameters of the diagnosed
disorders. We can calculate the lifetime risk of individuals with true disorder A
and also diagnosed as having disorder A as
KTA DA ¼ð 1   MTAÞKTA
and likewise for other combinations.
KTA_DB¼MTA KTA, KTB_DB¼(1 MTB) KTB and KTB_DA¼MTB KTB.F r o m
these, we can calculate the lifetime probabilities of being diagnosed with
disorder A or B as
KDA ¼ KTA DA+KTB DA and KDB ¼ KTB DB+KTA DB
The diagnosis misclassiﬁcation rate, the proportion of those diagnosed as
having disorder A, but truly having disorder B, is MDA¼KTB_DA/KDA,a n d
similarly MDB¼KTA_DB/KDB.
Genetic parameters estimated from observable data are based on lifetime
risks of the diagnosed disorders in probands and their relatives. With real data,
these genetic parameters (heritabilities, genetic correlation, common environ-
mental components) are estimated using maximum likelihood techniques,
which optimize the information from different types of relatives, and simulta-
neously account for confounders such as age or sex. However, in the absence of
such confounders and with only one type of relative, genetic parameters can be
estimated using the classic equations derived by Falconer6 and Reich, James and
Morris7 from the lifetime risks of the diagnosed disorders in probands and their
relatives, that is, KDA and KDB and KDA/DA, KDB/DB, KDA/DB and KDB/DA;a s
before, the diagnosis before the slash (/) is of the proband, and after the slash is
of the relatives. Calculation of these lifetime risks depends on the ﬂow of
information from diagnosed disorder of the proband, to true disorder
of proband, to the true disorder of relative, to the diagnosed disorder of
relative. A number of steps are needed to calculate these risks.
KDA=DA ¼ MDAKTB=DA+ð1   MDAÞKTA=DA
¼ MDA½KTB=TB DA+KTB=TA DA +ð1   MDAÞ½KTA=TA DA+KTA=TB DA 
¼MDA½KTB=TBMTB+KTB=TAð1   MTAÞ +ð1   MDAÞ½KTA=TAð1   MTAÞ
+KTA=TBMTB :
Similar expressions, can be derived for KDB/DB, KDA/DB and KDB/DA as shown by
Kendler.5 From these risks, we can calculate the heritabilities on the liability
scale that would be estimated from the observed diagnostic classiﬁcations, h2
DA
and h2
DB and the genetic correlation between them rgD (see Appendix). Even in
the absence of misdiagnosis, the validity of these estimates depends on the
critical assumption that common environment does not have a role in
familiality. Comparison of the true genetic parameters and the parameters
estimated from the diagnostic classiﬁcation reﬂects the impact of the mis-
diagnosis between disorders.
Estimation of genetic parameters from genome-wide genotypes
Genome-wide genotypes can be used to estimate the proportion of variance in
case–control status explained by the genotyped variants.4 A linear model can be
used to describe the relationship between case–control status and random
additive genetic effects
y ¼ Xb+u+e
where y is a vector of 0,1, where 0 represent controls and 1 cases. b is a vector of
ﬁxed effects or covariates (such as sex or ancestry principal components), X is
an incidence matrix linking cases/controls to the ﬁxed effects appropriate to
them. u is a vector of additive genetic effects on the 0, 1 disease scale and e is a
vector of random error terms. The variance of y is V(y)¼Asu
2+Ise
2,w h e r esu
2
and se
2 are the variances of the genetic and error effects, I is the identity matrix
and A is a matrix of additive genetic similarity8 relationships calculated from
genome-wide genotypes so that element i,j of A i st h ea d d i t i v eg e n e t i c
relationship between individual i and individual j, and the cases and controls
have been selected so that the coefﬁcient of relationship between any pair is
small so that individuals are unrelated in the classical sense. The variances are
estimated by (restricted) maximum likelihood and the ratio of estimates
su
2/(su
2+se
2) is the proportion of variance in case–control status explained
by the genome-wide genotypes and so is heritability on this scale.
In the absence of ﬁxed effects other than the mean, su
2+se
2¼P(1 P), the
binomial variance of case–control status, where P is the proportion of cases
in the sample. Bivariate models can be applied to case and control sets
from two different disorders (A and B), estimating the additive genetic
variances accounted for by the genotypes suA
2 and suB
2, the additive genetic
covariance between suA,uB and the genetic correlation can be calculated as
suA,uB/(suAsuB).
Our interest is on the impact of misdiagnosis of cases on the estimated
genetic parameters. As before, we use the subscripts TA and TB to refer to
parameters of the true disorders A and B, and subscripts DA and DB to denote
the parameters of the diagnosed disorders. If we assume that the numbers of
cases and controls for true disorder A are NcaseTA and NcontrolA, and similarly
for disorder B there are NcaseTB cases and NcontrolB controls. As before, MTA is
the proportion of true A cases that are misdiagnosed as having disorder B and
MTB is the proportion of true B cases that are misdiagnosed as having disorder
A. We can calculate the number of cases that have diagnosis A or B,
NcaseDA ¼ð 1   MTAÞNcaseTA+MTBNcaseTB
NcaseDB ¼ð 1   MTBÞNcaseTB+MTANcaseTA
We can calculate the genetic variance and covariances that will be attributed to
the diagnosed disorders as a function of the variances and covariances of the
true disorders. The proportional allocation of true variance/covariance com-
ponents to diagnosed variance/covariance components is represented in the
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s2
uDA ¼
ð1   MTAÞ
2N2
caseTAs2
uTA+M2
TBN2
caseTBs2
uTB+2ð1   MTAÞMTBNcaseTANcaseTBsuTA;uTB
N2
caseDA
s2
uDB ¼
ð1   MTBÞ
2N2
caseTBs2
uTB+M2
TAN2
caseTAs2
uTA+2ð1   MTBÞMTANcaseTANcaseTBsuTA;uTB
N2
caseDB
suDA;uDB ¼
½ðð1   MTAÞð1   MTBÞ+MTAMTBÞNcaseTANcaseTBsuTA;uTB+
ð1   MTAÞMTAN2
caseTAs2
TA+ð1   MTBÞMTBN2
caseTBs2
uTB 
NcaseDANcaseDB
The proportions of variance in case–control status explained by the SNPs on
the observed scale is then
s2
uDA
PDAð1   PDAÞ
and
s2
uDB
PDBð1   PBÞ
where
PDA ¼
NcaseDA
NcaseDA+NcontrolA
and PDA ¼
NcaseDB
NcaseDB+NcontrolD
The genetic correlation estimated for the diagnosed disorders is
rgD ¼
suDA;uDB
suDAsuDB
Lee et al4 provided a post-hoc transformation to convert the estimates on the
cases–control observed scale to the population liability scale. We do not need to
add this complication here, and in fact the correlation estimates on the
observed scale are good estimates of the correlation on the liability scale
(unpublished simulation results). We can use these relationships to investigate
the impact of misdiagnosis rates on estimates of the proportion of variance
explained by SNPs. In real life, we do not know the true diagnosis of
individuals, so we demonstrate the validity of these expressions using estimates
from real genome-wide data in which misclassiﬁcation is artiﬁcially imposed.
Application to genome-wide genotype data
We checked the validity of our derivations using the genome-wide genotype
data from the Wellcome Trust Case Control Consortium (WTCCC)9 consider-
ing two disorders with (to our knowledge) no excess of familial co-occurrence
and hence expected zero genetic correlation between disorders, namely Crohn’s
disease and type I diabetes. The WTCCC data sets included two control
samples. Here we allocate the 1958 birth cohort as the control sample for the
Crohn’s disease cases and the National Blood Service sample as the control set
for type I diabetes. A bivariate analysis of these case–control sets had been
undertaken by Lee et al,4 Supplementary Table 10) demonstrating a negligible
genetic correlation. Since our interest is to investigate the impact of imposed
misdiagnosis rates on parameter estimates, we will refer to Crohn’s disease as
disorder A and type I diabetes as disorder B, in order to emphasize that our
estimates result from artiﬁcially imposed misclassiﬁcation between the dis-
orders. Stringent quality control measures were applied to the case–control
data; this stringency is necessary as small errors for each SNP can be
accumulated to bias estimates of variance explained by SNPs,4 but in doing
so may remove some real signal. SNPs with minor allele frequencies o0.01 or
missing rates 40.001 were excluded as were SNPs, whose P-values were o0.05
for the Hardy–Weinberg equilibrium test and for missingness-difference
between cases and controls. A two-locus QC test10 was also applied to help
in identifying artefacts reﬂecting batch effects. Sex chromosomes were excluded
from the analysis. To keep only distantly related individuals, both individuals
from a pair with an estimated similarity relationship 40.05 were excluded
(which excludes relationships approximately closer than second-cousins),
considering all pairs of individuals across all case and control sets. After this
QC process, there were 1557 cases and 1384 controls for disorder A, and 1675
cases and 1195 controls for disorder B and a total of 155121 SNPs. We
estimated the genetic and environmental variances and covariances in a
bivariate model using an average information-REML that directly uses the
variance covariance matrix of all observations11 and is suitable for SNP-based
covariance structure among unrelated individuals. These estimates are those of
the ‘true’ disorders. We then repeated the analyses (i) after allocating 10% of
disorder A cases as disorder B cases and (ii) after allocating 10% of disorder A
cases as disorder B cases and vice versa. We repeated these random allocation
100 times and compared the mean estimates from these ‘diagnosed’ disorders
to their expectations based on the estimates from the ‘true’ disorders.
RESULTS
Estimation of genetic parameters from family data
To investigate the impact of misdiagnosis on estimation of genetic
parameters, we consider three examples based on psychiatric disorders
presented and justiﬁed by Kendler.5 These examples focus on real
scenarios, while at the same time consider different combinations of
the key parameters of the two disorders, namely lifetime risk and
recurrence risk to relatives. Kendler5 implicitly assumed that the true
genetic correlation between disorders was zero, thereby assuming that
co-occurrence of disorders within families resulted from misdiagnosis.
Here we relax that assumption and also consider scenarios where the
true genetic correlation is greater than zero.
Example 1: Schizophrenia (disorder A) and bipolar disorder
(disorder B)
We assume that the true lifetime risk of both schizophrenia and
bipolar disorder is 1%, that is, KTA¼KTB¼0.01 and recurrence risk to
relatives for both disorders of 8.0, that is, lTA¼lTB¼8.0. These
parameters equate to a heritability of liability of h2
TA¼h2
TB¼0.76. We
consider different combinations of misdiagnosis rates of the true
disorders MTA, MTB and consider the genetic correlation between
the true disorders to be Rgt¼0, 0.25, 0.5. Results are presented in
Table 1; those for Rgt¼0 directly correspond to Table 3 of Kendler.5
When there is no misdiagnosis between disorders MTA¼MTB¼0, the
genetic parameters estimated from the diagnosed disorders are the
same as the true genetic parameters, as expected. When the misdiag-
Table 1 Impact of misclassiﬁcation between schizophrenia
(disorder A) and bipolar disorder (disorder B) on estimation of
genetic parameters from recurrence risks in ﬁrst-degree relatives
rgT¼0 rgT¼0.25 rgT¼0.5
MTA MTB KDA KD h2
DA h2
DB rgD h2
DA h2
DB rgD h2
DA h2
DB rgD
0 0 1.00 1.00 76 76 0 76 76 25 76 76 50
5 5 1.00 1.00 72 72 21 73 73 39 74 74 59
10 10 1.00 1.00 68 68 37 69 69 51 71 71 67
15 15 1.00 1.00 65 65 50 66 66 61 69 69 74
20 20 1.00 1.00 62 62 62 64 64 70 67 67 80
30 30 1.00 1.00 56 56 82 59 59 86 63 63 91
40 40 1.00 1.00 52 52 95 56 56 96 61 61 98
50 50 1.00 1.00 51 51 100 55 55 100 60 60 100
0 5 1.05 0.95 74 75 11 74 75 32 75 75 54
0 1 01 . 1 0 0 . 9 07 17 4 2 07 27 4 3 87 47 4 5 8
0 1 51 . 1 5 0 . 8 56 97 3 2 87 17 3 4 47 37 3 6 2
0 2 01 . 2 0 0 . 8 06 77 1 3 46 97 1 4 87 27 1 6 5
0 3 01 . 3 0 0 . 7 06 56 9 4 56 76 9 5 77 16 9 7 0
Parameters follow those used in Table 3 of Kendler.5 All values are expressed as percentages.
The true disease prevalences are assumed to be 1% for both schizophrenia and bipolar disorder,
KTA¼KTB¼1%. True recurrence risks to ﬁrst-degree relatives are lTA¼lTB¼8.0. These
parameters equate to true heritabilities on the liability scale of hTA
2¼hTB
2¼0.76. MTA is the
proportion of true schizophrenia cases misclassiﬁed as bipolar disorder and MTB is the
proportion of true bipolar disorder cases misclassiﬁed as schizophrenia. The true genetic
correlation between the disorders is rgT¼0, 0.25,0.5. The estimated parameters based on
diagnosed prevalences and recurrences risks have subscript D.
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the diagnosed disorders are the same as the lifetime risk of the true
disorders, but as expected this breaks down when the misdiagnosis
rate between the disorders is unbalanced. As the misdiagnosis rates
increase, the estimates of the heritabilities based on the diagnosed
disorders decrease and the estimates of the genetic correlation
increase. As noted by Kendler,5 misdiagnosis has a more important
impact on the recurrence risks associated with the co-occurrence of
disorders within families than on the recurrence risks for the same
disorder. Hence, misdiagnosis has a greater impact on the estimates of
genetic correlation than on estimates of heritabilities. For example, a
10% misdiagnosis rate of true bipolar disorder being diagnosed as
schizophrenia would result in estimates of heritabilities of 0.71 and
0.74, respectively, for schizophrenia and bipolar disorder compared
with the true values of 0.76, but would generate an estimate of the
genetic correlation as 0.20 when the true value is zero. As might be
expected, the impact of misdiagnosis on estimates of genetic para-
meters from diagnosed disorders compared with the genetic
parameters for the true disorders decreases as the true genetic
correlation increases. Our methods allow us also to consider estimates
of genetic parameters estimated from diagnoses of second-degree
relatives. Misclassiﬁcation between diagnoses generates lower esti-
mates of heritabilities and genetic correlations from recurrence risks
of second-degree relatives than those estimated from ﬁrst-degree
relatives (results not shown). In real-life, sampling errors on recur-
rence risks to relatives are usually high, and so it is unlikely that
examination of inconsistency of estimates based on recurrence risks
from ﬁrst- and second-degree relatives would be conclusive.
Example 2: Schizophrenia (disorder A) and brief psychotic disorder
(disorder B)
We consider two disorders of approximately equal lifetime risk,
KTA¼KTB,¼0.01, but quite different evidence of familiality so that
lTA,¼ 8.0, lTB¼2.0. These parameters equate to a heritability of
liability of h2
TA¼0.76 and h2
TB¼0.21. We consider different combina-
tions of misdiagnosis rates of the true disorders MTA, MTB and
consider genetic correlation between the true disorders to be RgT¼0,
0.25, 0.5. Results are presented in Table 2; when RgT¼0 the scenarios
correspond to Table 5 of Kendler.5 Misclassiﬁcation of diagnosis has
less impact on the estimate of heritability for brief psychotic disorder,
because the absolute values are lower, but still generates non-negligible
inﬂation of the estimates of the genetic correlations.
Example 3: Schizophrenia (disorder A) and delusional disorder
(disorder B)
We consider two disorders that differ 10-fold in lifetime risk,
KTA¼0.01 and KTB¼0.001, and also differ in evidence of familiality
so that lTA,¼8.0, lTB¼2.0. These parameters equate to a heritability of
liability of h2
TA¼0.76 and h2
TB¼0.13. We consider different combina-
tions of misdiagnosis rates of the true disorders MTA,M TB and
consider genetic correlation between the true disorders to be rgT¼0,
0.25, 0.5. Results are presented in Table 3, and when rgT¼0t h e
scenarios correspond to Table 6 of Kendler.5 Misclassiﬁcation of
diagnosis has very little impact on the estimates of heritability for
either disorder. However, misdiagnosis of the more common disorder
(schizophrenia) to the less common disorder of only 1% generates an
estimated genetic correlation of 0.39. Misdiagnosis from the less
common disorder to the more common disorder has a negligible
impact on the estimates of the genetic correlation.
Estimation of genetic parameters from genome-wide genotypes
Using the stringently cleaned genome-wide genotypes from the
WTCCC, the proportion of variance in case–control status explained
by SNPs was 0.391 (SE 0.089) for disorder A and 0.470 (SE 0.093) for
disorder B, with a non-signiﬁcant genetic correlation of 0.023 (SE
0.155). The estimates of proportion of variance explained reported
Table 2 Impact of misclassiﬁcation between schizophrenia (disorder
A) and brief psychotic disorder (disorder B) on estimation of genetic
parameters from recurrence risks in ﬁrst-degree relatives
rgT¼0 rgT¼0.25 rgT¼0.5
MTA MTB KDA KD h2
DA h2
DB rgD h2
DA h2
DB rgD h2
DA h2
DB rgD
0 0 1.00 1.00 76 21 0 76 21 25 76 21 50
5 5 1.00 1.00 72 20 25 72 21 44 73 21 63
10 10 1.00 1.00 68 19 45 69 20 59 69 22 73
15 15 1.00 1.00 64 19 62 65 21 72 66 23 82
20 20 1.00 1.00 60 20 75 61 22 81 62 25 88
30 30 1.00 1.00 51 23 91 53 26 93 55 29 96
0 5 1.05 0.95 73 21 3 74 21 27 74 21 51
0 10 1.10 0.90 71 21 6 71 21 29 72 21 52
0 15 1.15 0.85 68 20 9 69 20 31 70 20 54
0 2 01 . 2 00 . 8 06 62 01 26 72 03 36 82 05 5
0 3 01 . 3 00 . 7 06 21 91 76 31 93 76 51 95 7
5 0 0.95 1.05 75 20 22 75 21 41 75 22 61
1 0 00 . 9 01 . 1 07 42 03 87 42 15 47 42 27 0
1 5 00 . 8 51 . 1 57 32 05 27 32 26 47 32 47 7
2 0 00 . 8 01 . 2 07 12 06 37 12 27 27 12 58 2
3 0 00 . 7 01 . 3 06 92 27 76 92 58 36 92 88 9
Parameters for the disorders follow those used in Table 5 of Kendler.5 All values are expressed
as percentages. The true disease prevalences are assumed to be 1% for both schizophrenia and
brief psychotic disorder, KTA¼KTB¼1%. True recurrence risks to ﬁrst-degree relatives are
lTA,¼8.0, lTB¼2.0. These parameters equate to true heritabilities on the liability scale of
h2
TA¼0.76 and h2
TB¼0.21. MTA is the proportion of true schizophrenia cases misclassiﬁed as
brief psychotic disorder and MTB is the proportion of true brief psychotic disorder cases
misclassiﬁed as schizophrenia. The true genetic correlation between the disorders is rgT¼0,
0.25,0.5. The estimated parameters based on diagnosed prevalences and recurrences risks
have subscript D.
Table 3 Impact of misclassiﬁcation between schizophrenia (disorder
A)and delusional disorder (disorder B) on estimation of genetic
parameters from recurrence risks in ﬁrst-degree relatives
rgT¼0 rgT¼0.25 rgT¼0.5
MTA MTB KDA KD h2
DA h2
DB rgD h2
DA h2
DB rgD h2
DA h2
DB rgD
0 0 1.00 0.10 76 13 0 76 13 25 76 13 50
1 1 0.99 0.11 76 12 39 76 13 54 76 14 70
2 2 0.98 0.12 76 12 63 76 13 72 76 15 82
3 3 0.97 0.13 75 13 77 75 15 83 75 16 89
5 5 0.96 0.15 75 16 91 75 18 93 75 20 95
1 1 01 . 0 00 . 1 07 51 24 27 61 25 77 61 37 2
2 2 01 . 0 00 . 1 07 51 27 17 51 37 87 51 58 5
3 3 01 . 0 00 . 1 07 41 48 77 41 69 07 41 89 3
0 10 1.01 0.09 76 13 1 76 13 25 76 13 50
0 20 1.02 0.08 75 12 1 75 12 26 75 12 51
0 50 1.05 0.05 73 12 3 74 12 27 74 12 51
1 0 0.99 0.11 76 12 39 76 13 54 76 14 70
2 0 0.98 0.12 76 12 62 76 13 72 76 15 81
5 0 0.95 0.15 75 16 90 75 18 92 75 20 94
Parameters follow those used in Table 6 of Kendler.5 All values are expressed as percentages.
The true disease prevalences are assumed to be 1% for schizophrenia and 0.1% delusional
disorder, KTA¼1% and KTB¼0.1%. True recurrence risks to ﬁrst-degree relatives are lTA,¼ 8.0,
lTB¼2.0. These parameters equate to true heritabilities on the liability scale of h2
TA¼0.76 and
h2
TB¼0.13. MTA is the proportion of true schizophrenia cases misclassiﬁed as delusional disorder
and MTB is the proportion of true delusional disorder cases misclassiﬁed as schizophrenia. The
true genetic correlation between the disorders is rgT¼0, 0.25,0.5. The estimated parameters
based on diagnosed prevalences and recurrences risks have subscript D.
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reported in Supplementary Table S10 of Lee et al;4 here we applied
more stringent QC and included 10 ancestry principle components,
thus avoiding artifactual inﬂuences, at the expense of the loss of real
signal. We use these observed ‘true’ parameters to calculate the
expected genetic parameters under the two misdiagnosis models.
The calculated genetic parameters agreed well with those estimated
from the data given for sampling variation (Table 4). Misclassiﬁcation
of a true disorder to the other diagnostic class decreases the estimates
of the proportion of variance explained by SNPs even though the total
variance in case–control status is little changed, PT(1 PT) vs
PD(1 PD). Misclassiﬁcation of diagnoses can generate a substantial
genetic correlation between the diagnosed disorders when the true
genetic correlation is zero. We considered a range of values for the true
variances and covariances explained by SNPs and a range of values for
the misclassiﬁcation rates and used the derived equations to examine
the impact on the parameters that would be estimated from the
diagnosed disorders. The conclusions drawn from these examples
paralleled the conclusions drawn when estimating genetic parameters
from family data. For example, in Figure 1 we compare four scenarios
in which we assume that the true number of cases and controls
for each disorder are equal. In Figure 1a, 60% of the variance in true
case–control status is explained by genome-wide SNPs for both
disorders, disorder A can be misdiagnosed as disorder B but not
vice versa; the true genetic correlation between disorders is zero. The
estimate of the proportion of variance explained for trait A is not
Table 4 The impact of misdiagnosis in estimating genetic parameter from genome-wide genotypes
Proportion of variance explained by SNPs
MTA MTB
‘True’ (T) or diagnosed
(D) disorders
Estimated from data
or calculateda suA
2 suB
2 s2
uA,uB Disorder A Disorder B rg
0 0 T Estimated 0.096 0.112 0.002 0.391 (0.089) 0.470 (0.093) 0.023 (0.155)
0.1 0 D Estimated 0.096 0.092 0.013 0.387 (0.029) 0.393 (0.023) 0.139 (0.055)
D Calculated 0.096 0.095 0.010 0.385 0.396 0.109
0.1 0.1 D Estimated 0.075 0.093 0.024 0.304 (0.034) 0.388 (0.035) 0.296 (0.092)
D Calculated 0.079 0.093 0.021 0.316 0.383 0.244
aCalculated using equations in text based on the estimates from the true disorders and misclassiﬁcation rates.
MTA proportion of disorder A cases labelled as disorder B cases; MTB proportion of disorder B cases labelled as disorder A cases. Values in parentheses are the standard errors for the parameters
estimated when MTA¼MTB¼0, but otherwise are the standard deviations over 100 replicates.
Figure 1 Illustrations of the impact of misdiagnosis rate of true disorder A cases as disorder B (MTA) on parameters estimated by genome-wide SNPs:
Proportion of variance in case–control status explained by SNPs for disorder A (solid line), disorder B (dashed line) and the genetic correlation between
disorders A and B explained by SNPs (dotted line). (a) Proportion of variance that can be explained by SNPs for true disorders A and B¼0.6, true genetic
correlation 0, no misdiagnosis of true disorder B cases as disorder A, MTB¼0. (b)A s( a) but proportion of variance that can be explained by SNPs for true
disorders A and B¼0.2. (c)A s( b)b u tMTB¼MTA.( d)A s( c) but true genetic correlation between disorders is 0.5. Note: the dashed line does not show when
the values are the same as for the solid line.
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In contrast, the estimate of the variance explained by SNPs for
disorder B decreases with an increasing contamination of diagnosis
by disorder A cases. For example, for a 10% misdiagnosis rate, the
estimate of variance explained by SNPs decreases from 0.60 to 0.50
and this is accompanied by an estimate of the genetic correlation of
0.10. Figure 1b repeats the analysis but now considers two disorders
with a lower genetic contribution to their etiology so that only 0.2 of
the variance in true case–control status is explained by SNPs. In this
case, the reduction in variance explained by SNPs for disorder B under
10% misdiagnosis from disorder A is small (from 0.20 to 0.17), but
this is still accompanied by the same inﬂated estimate of the genetic
correlation of 0.10. Figure 1c repeats Figure 1b, but includes reciprocal
misdiagnosis between the two disorders. Now the variance explained
by SNPs is biased downwards a little for both disorders (from 0.20 to
0.16, when the misdiagnosis rates are 10%), but the impact on the
genetic correlation is more pronounced (estimated to be 0.22 when
MTA¼MTB¼0.1). Figure 1d repeats Figure 1c except that now the true
genetic correlation between the disorders is 0.5. Now we see that the
impact of misdiagnosis is less pronounced: the estimates of variance
explained by SNPs are less biased (0.18) and the estimated genetic
correlation is proportionally less inﬂated (the slope of the relationship
with MTA is reduced compared with Figure 1c) and the correlation is
estimated to be 0.65 at a reciprocal misdiagnosis rate of 10%.
DISCUSSION
The era of genome-wide genotyping will allow direct estimation of a
shared genetic etiology between disorders in a more direct and widely
available way than has hitherto been possible. Until now evidence for a
shared genetic etiology could only be achieved through co-occurrence
of disorders in related individuals (ie, in family, twin or adoptee
samples). The use of genome-wide genotypes from case–control
studies to estimate genetic correlations averts two potential problems
associated with estimating genetic correlations from family data. First,
estimates could be obtained even for very rare disorders where it
would be infeasible to collect adequate numbers of co-occurrences
within related individuals. Second, the estimates of genetic correla-
tions from genome-wide genotypes are derived using such distant
relatives that contamination by shared environmental factors seems
unlikely.
The current study was motivated by a desire to understand the
impact of misclassiﬁcation on the estimates of genetic parameters
obtained by analysis of genome-wide genotypes. One of the reasons to
be concerned about this problem is that the drive to increase sample
size to obtain power to detect alleles of small effect has sometimes
meant reduced attention and resources given to diagnostic evalua-
tions. Thus, in striving for the samples needed to detect risk alleles for
complex disorders we may be increasing the chances of diagnostic
misclassiﬁcations adding ‘noise’ to the system. For example, a case–
control study of 5000 cases and 5000 controls has the power equivalent
to that of a study of only 3200 cases and 3200 controls, or 64% of the
sample size, when 20% of the case sample has been misdiagnosed
(assuming no true pleiotropy between the disorders at the risk locus),
see online Supplementary information.
Our analyses found that the proportion of variance explained by
SNPs is underestimated in the presence of diagnostic misclassiﬁcation
compared with the variance explained by SNPs of the true disorder.
However, under most realistic misclassiﬁcation rates, this underesti-
mation is likely to be modest and well with the sampling error of the
estimate. By contrast, misclassiﬁcation can generate substantial esti-
mates of genetic correlation and the impact is greatest when there is
no genetic correlation between the true disorders (Tables 1–3,
Figure 1). This latter point is obvious if we consider the most extreme
example, where the true genetic correlation between the disorders is 1.
In this case, the disorders are genetically the same, but environmental
or stochastic process generates different phenotypes, then (of course)
misclassiﬁcation has no impact on the estimation of the genetic
parameters. To benchmark these results using genotype data, we
considered the impact of diagnostic misclassiﬁcation on the estima-
tion of genetic parameters from family data. To do this, we extended
the derivations of Kendler,5 who considered the impact of diagnostic
misclassiﬁcation on the recurrence risks to relatives. Our extension
makes the crucial assumption that the recurrence risks to relatives
reﬂect only additive genetic rather than common environmental
causes of familiality. We show that diagnostic misclassiﬁcation has
similar impact on the genetic parameters estimated from family data
as it does from genome-wide genotypes.
We can conclude that variance explained by SNPs for a disorder is a
lower limit of the heritability. It is a lower limit, ﬁrstly because the
SNPs do not represent all of the variance in the genome, but even if
they did, diagnostic misclassiﬁcation will tend to lead to under-
estimates. In contrast, in the absence of diagnostic misclassiﬁcation,
the genetic correlation between disorders estimated from genome-
wide genotypes is an unbiased estimate of the true genetic correlation,
if we can assume that the genetic correlation is the same across the risk
allele frequency spectrum (as less common and rare risk alleles are
under-represented on genome-wide genotyping platforms). However,
in the presence of diagnostic misclassiﬁcation, the estimated genetic
correlation will provide an upper bound on the true genetic correla-
tion; only quantiﬁcation of the misclassiﬁcation rates can provide
some insight into the extent of the upward bias of the genetic
correlation. However, substantial reciprocal misdiagnosis rates would
be needed for a substantial estimate of the genetic correlation (40.2)
to be achieved when the true genetic correlation is zero.
The conundrum then is how to estimate the magnitude of diag-
nostic misclassiﬁcation and determine its biasing effects on observed
genetic correlations. For example, it is reasonable to expect that studies
which personalize diagnostic assessments using a standardized
research protocol would produce lower misclassiﬁcation rates than
those observed using diagnoses recorded for clinical purposes as are
typically done in data from national registries. For example, Lichten-
stein et al (2007)12 used the National Swedish records to estimate the
heritabilities of schizophrenia and bipolar disorder and the genetic
correlation between them. To overcome problems from misclassiﬁca-
tion the authors undertook additional analyses and individuals
required two hospital admissions to qualify as having a disorder.
Their estimated genetic correlation between schizophrenia and bipolar
disorder was 0.60; misclassiﬁcation rates of 20% or more would be
needed for this to reﬂect a true null genetic correlation.
Investigators will need to consider methods to reduce a priori
misclassiﬁcation in the design of a study or, alternatively, to detect it
post-hoc at the data-analytical stage. For example, for many disorders,
clinical manifestations are less speciﬁc early in the disease course but
become more typical with time. This might suggest that data collec-
tion projects exclude subjects in the ﬁrst several years after ﬁrst
presentation to reduce risk of misclassiﬁcation. Alternatively, if the
hypothesis that diagnostic error rates decline with length of illness is
true, then if a genetic correlation was observed between two such
disorders that arises in part through misclassiﬁcation, the correlation
should decline if subjects diagnosed early in the course of illness are
excluded from analysis. For a number of medical disorders, subjects
can present with classical clinical presentations or with mixed features.
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European Journal of Human GeneticsIn psychiatry, the diagnosis of ‘schizo-affective disorder’ typically has
clinical features both of schizophrenia and mood disorders.13 In
gastroenterology, non-speciﬁc inﬂammatory bowel disease patients
typically have symptoms both of ulcerative colitis and Crohn’s
disease.14 Such cases likely have a higher chance of misclassiﬁcation
and their a priori exclusion should reduce the chances of a misclassi-
ﬁcation-driven genetic correlation. Alternatively, their exclusion at the
data analysis stage should reduce the observed genetic correlation.
Limitations
These results should be interpreted in the context of several potential
conceptual and/or methodological limitations. First, we do not con-
sider the problem of misdiagnosis between having a disorder and
having no disorder at all. The impact of this diagnostic problem
should reduce estimates of genetic variance for a disorder and co-
variance with a related disorder. Second, we have not considered the
realistic scenario that misclassiﬁcation rates would vary in a systematic
way between collection sites in a multicenter collaborative project.
Between-site differences might include the average age of the cases, the
quality of diagnostic information (eg, with large potential differences
between samples ascertained at in- vs out-patient facilities). Third, we
have assumed that the joint distribution of the liabilities of the two
disorders can be approximately represented by a bivariate normal
distribution.
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APPENDIX
The derivations of Falconer6 and Reich, James and Morris7
show that we can calculate heritability on the liability scale
(h2) from the lifetime risk of disease (K) and the recurrence risk to
relatives lR. Then the lifetime probability of disease in the relatives is
KR¼lRK. Under the liability threshold model, those with pheno-
typic liability, Z B N(0,1), greater than the threshold t are
diseased such that distribution p(Z 4 t)¼F(t)¼K and F(tR)¼KR.i
is the mean liability of the diseased group in the population, cal-
culated as i¼y/K, where y is the height of the normal curve at
threshold t.a R is the coefﬁcient of relationship between the
relatives and probands, for example, if relatives are children of
probands aR ¼0.5.
h2 ¼
t   tR
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1  ð 1   t=iÞðt2   t2
RÞ
p
aRði+ði   tÞt2
RÞ
Similarly, the genetic correlation between two disorders 1 and 2 is
calculated as
rg ¼
t2   t2R
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1  ð 1   t1=i1Þðt2
2   t2
2RÞ
p
h1h2aRði1+ði1   t1Þt2
RÞ
where the proband has disorder 1 and the relative has disorder 2. The
d i s o r d e r sh a v el i f e t i m er i s k so fK1 and K2 and the lifetime risk of
disorder 2 in relatives of disorder 1 probands is K2R.
Supplementary Information accompanies the paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)
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